ACTON, Mass.--(BUSINESS WIRE)--Neuroptix Corporation, a leading pioneer in the early detection of Alzheimer’s Disease through a non-invasive eye test, today announced that it has named Gerald D. Cagle, Ph.D., as the company’s first Chief Operating Officer.
